These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38047168)

  • 1. Impact of SARS-CoV-2 AstraZeneca Vaccine on Safety and Blood Elements of Egyptian Healthcare Workers.
    Meshref TS; Hamad DA; Aly MM; Kamal DT; Elkhayat MR; Elghazally SA
    Indian J Occup Environ Med; 2023; 27(3):241-248. PubMed ID: 38047168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative SARS-CoV-2 anti-spike responses to Pfizer-BioNTech and Oxford-AstraZeneca vaccines by previous infection status.
    Eyre DW; Lumley SF; Wei J; Cox S; James T; Justice A; Jesuthasan G; O'Donnell D; Howarth A; Hatch SB; Marsden BD; Jones EY; Stuart DI; Ebner D; Hoosdally S; Crook DW; Peto TEA; Walker TM; Stoesser NE; Matthews PC; Pouwels KB; Walker AS; Jeffery K
    Clin Microbiol Infect; 2021 Oct; 27(10):1516.e7-1516.e14. PubMed ID: 34111577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance of Antibody Response in Egyptian Healthcare Workers Vaccinated with ChAdOx1 nCoV-19 Vaccine during Delta and Omicron Variants Pandemic: A Prospective Study.
    Hammad NM; Kadry HM; Malek MM; Bahgat SM; Abdelsalam NM; Afifi AHM; Abo-Alella DA
    Vaccines (Basel); 2022 Oct; 10(10):. PubMed ID: 36298571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibody Response After Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthcare Workers with and without Previous COVID-19 Infection: A Prospective Observational Study].
    Özgür D; Tütüncü EE
    Mikrobiyol Bul; 2022 Jan; 56(1):36-48. PubMed ID: 35088958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and tolerability of the novel 2019 coronavirus disease (COVID-19) vaccines among people with epilepsy (PwE): A cross-sectional study.
    Massoud F; Ahmad SF; Hassan AM; Alexander KJ; Al-Hashel J; Arabi M
    Seizure; 2021 Nov; 92():2-9. PubMed ID: 34391030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective Evaluation of Side-Effects Following the First Dose of Oxford/AstraZeneca COVID-19 Vaccine among Healthcare Workers in Saudi Arabia.
    Darraj MA; Al-Mekhlafi HM
    Vaccines (Basel); 2022 Jan; 10(2):. PubMed ID: 35214681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Side effects after COVID-19 vaccinations among residents of Poland.
    Andrzejczak-Grządko S; Czudy Z; Donderska M
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(12):4418-4421. PubMed ID: 34227078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Side effects of Sputnik V, Oxford-AstraZeneca, Sinopharm, and Covaxin and their associations with other variables among healthcare workers of a tertiary hospital in Iran.
    Oghazian S; Tavanaei Tamanaei T; Haghighi R; Faregh M; Oghazian MB
    Int Immunopharmacol; 2023 Apr; 117():109784. PubMed ID: 36812676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reported COVID-19 vaccines side effects among Jordanian population: a cross sectional study.
    Omeish H; Najadat A; Al-Azzam S; Tarabin N; Abu Hameed A; Al-Gallab N; Abbas H; Rababah L; Rabadi M; Karasneh R; Aldeyab MA
    Hum Vaccin Immunother; 2022 Dec; 18(1):1981086. PubMed ID: 34614383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-reported side effects of the Oxford AstraZeneca COVID-19 vaccine among healthcare workers in Ethiopia, Africa: A cross-sectional study.
    Yesuf EA; Riad A; Sofi-Mahmudi A; Sudhakar M; Mekonnen A; Endalkachew S; Mama F; Muhidin S; Ayele B; Yahya M; Usman A; Abafita J; Klugar M
    Front Public Health; 2022; 10():937794. PubMed ID: 35928493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxford-AstraZeneca COVID-19 vaccine: need of a reasoned and effective vaccine campaign.
    Vallée A; Chan-Hew-Wai A; Bonan B; Lesprit P; Parquin F; Catherinot É; Choucair J; Billard D; Amiel-Taieb C; Camps È; Cerf C; Zucman D; Fourn E
    Public Health; 2021 Jul; 196():135-137. PubMed ID: 34198072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perceptions and experiences of COVID-19 vaccines' side effects among healthcare workers at an Egyptian University Hospital: a cross-sectional study.
    Orebi HA; Emara HE; Alhindi AA; Shahin MR; Hegazy AH; Kabbash IA; Saied SM
    Trop Med Health; 2022 May; 50(1):37. PubMed ID: 35637513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety Profile of COVID-19 Vaccines among Healthcare Workers in Poland.
    Paczkowska A; Hoffmann K; Michalak M; Hans-Wytrychowska A; Bryl W; Kopciuch D; Zaprutko T; Ratajczak P; Nowakowska E; Kus K
    Vaccines (Basel); 2022 Mar; 10(3):. PubMed ID: 35335066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse Events following AstraZeneca COVID-19 Vaccine in Saudi Arabia: A Cross-Sectional Study among Healthcare and Nonhealthcare Workers.
    Alghamdi AA; Alkazemi A; Alissa A; Alghamdi I; Alwarafi G; Waggas HA
    Intervirology; 2022; 65(2):104-109. PubMed ID: 34544075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term immune response after inactivated SARS-CoV-2 (CoronaVac®, Sinovac) and ChAdOx1 nCoV-19 (Vaxzevria®, Oxford-AstraZeneca) vaccinations in health care workers.
    Jantarabenjakul W; Chantasrisawad N; Puthanakit T; Wacharapluesadee S; Hirankarn N; Ruenjaiman V; Paitoonpong L; Suwanpimolkul G; Torvorapanit P; Pradit R; Sophonphan J; Putcharoen O
    Asian Pac J Allergy Immunol; 2022 Sep; 40(3):269-277. PubMed ID: 34717527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological responses and adverse reactions of the heterologous second booster dose of BNT162b2 after two-dose CoronaVac for COVID-19 vaccination in healthcare workers of Faculty of Medicine, Naresuan University.
    Makanut S; Wangteeraprasert A; Jitpewngam W; Ngoenkam J; Pongcharoen S
    Vaccine; 2023 Jun; 41(29):4335-4340. PubMed ID: 37301707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tracking Side Effects of the COVID-19 Vaccine in Mymensingh District of Bangladesh.
    Khan MK; Ferdous J; Akhter S; Esha AM; Islam M
    Mymensingh Med J; 2022 Jan; 31(1):1-9. PubMed ID: 34999672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Antibody Levels Produced by Pfizer, AstraZeneca, and Sinopharm Vaccination in COVID-19 Patients in Erbil City-Iraq.
    Majed SO
    Cell Mol Biol (Noisy-le-grand); 2023 Mar; 69(3):103-112. PubMed ID: 37300682
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.